SAS Output

24-MAR-2017 18:10

MMYEL ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1211-MM,High Risk, RVD+/-ELO 1 T 1 RVD/Elo Dose Level 1 110 8 0 0 0 0 0 02/13/2013 195 65
        4 RVD   68 7 0 0 0 0      
        5 RVD/Elo   66 10 0 0 0 0      
            142 17 0 0 0 0      
 
  S1304-MM,relapsed/refractory, Car+Dex 1 N 1 Dex+Low Dose Carfilzomib 140 72 0 0 0 0 0 02/12/2014 5 2
        2 Dex+High Dose Carfilzomib   71 0 0 0 0 0      
            143 0 0 0 0 0      
 
    2 Y 3 Dex+High Dose Carfilzomib 140 22 0 0 0 0 0 02/12/2014    
            22 0 0 0 0 0      
 
  S0777-MM, Len Dex +/- Bortezomib 1 N 1 Lenalidomide/Dex 484 261 0 0 0 0 0 07/28/2008 18 5
        2 Bortezomib/Lenalidomide/Dex   264 0 0 0 0 0      
            525 0 0 0 0 0      
 
Yes E1A11-MM, frontline, BLD vs CLD 1 E Total Registrations   106 71 46 21 9 1 03/05/2014 300 125
            106 71 46 21 9 1      
 
  E3A06-AMM, Lenalidomide vs Observation 0 E Total Registrations   31 8 5 2 1 0 02/01/2011 271 122
            31 8 5 2 1 0      
 
    1 E Total Registrations   33 4 1 1 0 0 02/01/2011    
            33 4 1 1 0 0      
 
No A061402-Solitary Plasmacytoma, adj sys+Zol vs Zol 0 E Total Registrations   1 1 1 1 0 0 01/27/2017    
            1 1 1 1 0 0      
 
  E1A11-MM, frontline, BLD vs CLD 0 E Total Registrations   110 79 50 22 9 1 03/05/2014 300 125
            110 79 50 22 9 1      
 
    2 E Total Registrations   22 10 10 5 4 1 03/05/2014    
            22 10 10 5 4 1      
 

24-MAR-2017 18:10

MMYEL Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S0777 MM, Len Dex +/- Bortezomib 2 Autologous Transplant 01-Apr-08